Improving the detection limits of antispasmodic drugs electrodes by using modified membrane sensors with inner solid contact.
Three coated wire electrodes (CWEs) for the antispasmodic drugs; dicyclomine (Dc), mebeverine (Mv) and drotaverine (Dv) hydrochlorides were developed. Each electrode based on ion-associate of a heteropoly anion with the drug cation incorporated in membrane sensor modified with graphite and deposited on silver internal solid contact. The influence of addition of graphite to the membranes and the type of the internal solid contact on the potentiometric responses of the electrodes was investigated. The characteristics of the new electrodes were compared to the characteristics of previously reported traditional liquid inner contact electrodes of the same drugs. The lower detection limits of the proposed electrodes were somewhat better than those observed with the corresponding liquid contact ISEs and reached (1.2-2.0)x10(-7)M. The potentiometric selectivity of the CWEs revealed a significant improvement and much faster response times compared to the liquid contact ISEs. The practical utility of each electrode has been demonstrated by using it successfully in potentiometric determination of its respective drug in pharmaceutical preparations both in batch and flow injection conditions. Each electrode was also used as an indicator electrode in the potentiometric titration of the drug against standard silicotungstic acid and in potentiometric determination of the drug concentration in urine samples.
Ibrahim
Hosny
H
Department of Chemistry, Faculty of Science, Cairo University, Cairo 111214, Egypt. dr_hosny@yahoo.com
Issa
Y M
YM
Abu-Shawish
Hazem M
HM
D000284:Administration, Oral; D015374:Biosensing Techniques / Q000295:instrumentation* / Q000379:methods; D004304:Dosage Forms; D005240:Feasibility Studies; D017022:Flow Injection Analysis; D006108:Graphite / Q000737:chemistry; D006801:Humans; D017736:Ion-Selective Electrodes; D008297:Male; D008567:Membranes, Artificial; D010276:Parasympatholytics / Q000008:administration & dosage / Q000032:analysis / Q000652:urine*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*; D011199:Potentiometry; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D017640:Silicates / Q000737:chemistry; D012834:Silver / Q000737:chemistry; D012996:Solutions / Q000737:chemistry; D013607:Tablets / Q000032:analysis; D013997:Time Factors; D017973:Tungsten Compounds / Q000737:chemistry; D014867:Water / Q000737:chemistry
D004304:Dosage Forms; D008567:Membranes, Artificial; D010276:Parasympatholytics; D004364:Pharmaceutical Preparations; D017640:Silicates; D012996:Solutions; D013607:Tablets; D017973:Tungsten Compounds; D014867:Water; D012834:Silver; D006108:Graphite; C021746:silicotungstic acid